I rate Arm Holdings (ARM) a Buy with a $544 price target, implying 64% upside from $332 per share. The main growth drivers ...
Sabra Health Care REIT remains a Buy, driven by its aggressive pivot into the Seniors Housing Operating Portfolio model. Read ...
NDTV Profit on MSN
Lenskart shares rise 3%, near 52-week high after JPMorgan initiates bullish coverage — check target price
Brokerage sets a target price of Rs 635, citing growth in India and overseas markets and expectations of operating leverage.
BofA raised its price target, but the real story is the software business ...
DVIRC CEO Chris Scafario breaks down the 2030 vision to modernize local factories, scale supply chains, and integrate AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results